Stay updated with breaking news from Decipher Prostate Genomic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Veracyte, Inc. , a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance for prostate...
Veracyte, Inc. , a leading cancer diagnostics company, today announced that its Decipher Prostate Genomic Classifier is the only gene expression test to receive a “Level 1B” evidence rating in...
FinancialContent fully hosted finance channel
Veracyte, Inc. announced that new data to be shared at the 2023 American Society of Clinical Oncology Annual Meeting demonstrate the ability of the company’s Decipher Genomics Resource for... | June 11, 2023
Veracyte, Inc. announced that data published in the journal Cancer show the ability of a novel gene expression signature to classify prostate cancer into distinct molecular subtypes that may inform... | May 3, 2023